Diacarb

Country of origin: Poland, Starograd Pharmaceutical Plant, Poland Poland

Pharm-Group: Diuretics - carbonic anhydrase inhibitors

Manufacturers: Polpharma pharmaceutical plant SA (Poland), Starograd pharmaceutical plant, Poland (Poland)

International name: Acetazolamide

Dosage forms: tablets 250 mg

Composition: Active substance - acetazolamide.

Indications for use: Glaucoma; epilepsy (in combination with anticonvulsants); edema (due to pulmonary heart failure or caused by drugs); mountain sickness

Contraindications: Hypersensitivity, hyponatremia, hypokalemia, adrenal insufficiency, renal or hepatic failure, liver cirrhosis, urolithiasis (with hypercalciuria), hyperchloremic acidosis, chronic decompensated angle-closure glaucoma, diabetes mellitus, uremia, lactation. Restrictions on use: Pulmonary embolism, emphysema, pregnancy.

Side effects: Hearing impairment/tinnitus, drowsiness, taste disturbance, transient myopia, disorientation, paresthesia, convulsions; loss of appetite, nausea, vomiting, diarrhea, melena, liver failure; metabolic acidosis and electrolyte imbalance; urticaria, increased sensitivity to light, polyuria, hematuria, glucosuria.

Interaction: The diuretic effect is weakened by acid-forming diuretics and enhanced by theophylline.

Overdose: No information.

Special instructions: If skin changes or changes in the blood picture occur, the drug should be discontinued immediately. Use caution when using acetazolamide concomitantly with acetylsalicylic acid (in high doses). During long-term use, monitoring of serum electrolyte levels is necessary, as well as monitoring of peripheral blood patterns. Should not be used during work by vehicle drivers and people whose profession involves increased concentration of attention.

Literature: Encyclopedia of Medicines 2005.